1. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012;44(11):805-14. [
Link] [
DOI:10.3109/00365548.2012.693197] [
PMID]
2. Weiss LM, Kim K. Toxoplasma gondii: the model apicomplexan. Int J Parasitol. 2004;34(3):423-32. [
Link] [
DOI:10.1016/j.ijpara.2003.12.009] [
PMID] [
PMCID]
3. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005;6(1):41-61. [
Link] [
DOI:10.1079/AHR2005100]
4. Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol. 2013;114:125-45. [
Link] [
DOI:10.1016/B978-0-444-53490-3.00008-X] [
PMID] [
PMCID]
5. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385-94. [
Link] [
DOI:10.1016/j.ijpara.2009.04.003] [
PMID]
6. Bojar I, Szymanska J. Environmental exposure of pregnant women to infection with Toxoplasma gondii-state of the art. Ann Agric Environ Med. 2010;17(2):209-14. [
Link] [
PMID]
7. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009;49(6):878-84. [
Link] [
DOI:10.1086/605433] [
PMID]
8. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, et al. Congenital toxoplasmosis in France in 2007: First results from a national surveillance system. Euro Surveill. 2010;15(25):19600. [
Link] [
DOI:10.2807/ese.15.25.19600-en]
9. Rorman E, Zamir CS, Rilkis I, Ben-David H. Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol. 2006;21(4):458-72. [
Link] [
DOI:10.1016/j.reprotox.2005.10.006] [
PMID]
10. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363(9425):1965-76. [
Link] [
DOI:10.1016/S0140-6736(04)16412-X]
11. Remington JS, R McLeod, P Thulliez, G Desmonts. Toxoplasmosis.Ch. 31. In: Remington JS, Klein JO, Wilson CB, Baker CJ. Infectious Diseases of Fetus and Newborn Infant, 6tn edition. Philadelphia: Elsevier-Saunders; 2006. p.947-1091. [
Link] [
DOI:10.1016/B0-72-160537-0/50033-5]
12. Kieffer F, Wallon M. Congenital toxoplasmosis. Handb Clin Neurol. 2013;112:1099-101. [
Link] [
DOI:10.1016/B978-0-444-52910-7.00028-3] [
PMID]
13. Pereira KS, Franco RM, Leal DA. Transmission of toxoplasmosis (Toxoplasma gondii) by foods. Adv Food Nutr Res. 2010;60:1-19. [
Link] [
DOI:10.1016/S1043-4526(10)60001-0]
14. Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, et al. Toxoplasmosis in pregnancy: Prevention, screening, and treatment. J Obstet Gynaecol Can. 2013;35(1):78-81. [
Link] [
DOI:10.1016/S1701-2163(15)31053-7]
15. Jones J, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Physician. 2003;67(10):2131-8. [
Link] [
PMID]
16. Kaye A. Toxoplasmosis: Diagnosis, treatment, and prevention in congenitally exposed infants. J Pediatr Health Care. 2011;25(6):355-64. [
Link] [
DOI:10.1016/j.pedhc.2010.04.008] [
PMID]
17. Jongert E, Roberts CW, Gargano N, Förster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz. 2009;104(2):252-66. [
Link] [
DOI:10.1590/S0074-02762009000200019]
18. Henriquez FL, Woods S, Cong H, McLeod R, Roberts CW. Immunogenetics of Toxoplasma gondii informs vaccine design. Trends Parasitol. 2010;26(11):550-5. [
Link] [
DOI:10.1016/j.pt.2010.06.004] [
PMID]
19. Innes EA. Vaccination against Toxoplasma gondii: An increasing priority for collaborative research?. Expert Rev Vaccines. 2010;9(10):1117-9. [
Link] [
DOI:10.1586/erv.10.113] [
PMID]
20. Varella IS, Canti IC, Santos BR, Coppini AZ, Argondizzo LC, Tonin C, et al. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil. Memórias do Instituto Oswaldo Cruz. 2009;104(2):383-8. [
Link] [
DOI:10.1590/S0074-02762009000200037]
21. 21 -Bénard A, Petersen E, Salamon R, Chêne G, Gilbert R, Salmi LR, et al. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill. 2008;13(15). pii:18834. [
Link] [
DOI:10.2807/ese.13.15.18834-en] [
PMID] [
PMCID]
22. Gómez-Marin JE, de-la-Torre A, Angel-Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis. 2011;5(5):e1195. [
Link] [
DOI:10.1371/journal.pntd.0001195] [
PMID] [
PMCID]
23. Kravetz J. Congenital toxoplasmosis. BMJ Clin Evid. 2013;pii:0906. [
Link]
24. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185(Suppl 1):S73-S82. [
Link] [
DOI:10.1086/338827] [
PMID]
25. Stray-Pedersen B. 5 Toxoplasmosis in pregnancy. Baillière Clin Obstet Gynaecol. 1993;7(1):107-37. [
Link] [
DOI:10.1016/S0950-3552(05)80149-X]
26. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: The Platelia Toxo IgM test. J Clin Microbiol. 1997;35(1):174-8. [
Link] [
PMID] [
PMCID]
27. 27 -Saadatnia G, Mohamed Z, Ghaffarifar F, Osman E, Moghadam ZK, Noordin R. Toxoplasma gondii excretory secretory antigenic proteins of diagnostic potential. APMIS. 2012;120(1):47-55. [
Link] [
DOI:10.1111/j.1600-0463.2011.02810.x] [
PMID]
28. Flori P, Chene G, Varlet M, Sung RT. Toxoplasma gondii serology in pregnant woman: Characteristics and pitfalls. Ann Biol Clin (Paris). 2009;67(2):125-33. [French] [
Link]
29. Saadatnia G, Ghaffarifar F, Khalilpour A, Amerizadeh A, Rahmah N. A Toxoplasma gondii 10 kDa in vitro excretory secretory antigen reactive with human IgM and IgA antibodies. Trop Biomed. 2011;28(3):606-14. [
Link] [
PMID]
30. Golkar M, Azadmanesh K, Khalili G, Khoshkholgh-Sima B, Babaie J, Mercier C, et al. Serodiagnosis of recently acquired Toxoplasma gondii infection in pregnant women using enzyme-linked immunosorbent assays with a recombinant dense granule GRA6 protein. Diagn Microbiol Infect Dis. 2008;61(1):31-9. [
Link] [
DOI:10.1016/j.diagmicrobio.2007.09.003] [
PMID]
31. Kotresha D, Noordin R. Recombinant proteins in the diagnosis of toxoplasmosis. APMIS. 2010;118(8):529-42. [
Link] [
DOI:10.1111/j.1600-0463.2010.02629.x]
32. Elyasi H, Babaie J, Fricker-Hidalgo H, Brenier-Pinchart MP, Zare M, Sadeghiani G, et al. Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy. Clin Vaccine Immunol. 2010;17(9):1349-55. [
Link] [
DOI:10.1128/CVI.00199-10] [
PMID] [
PMCID]
33. Golkar M, Shokrgozar MA, Rafati S, Musset K, Assmar M, Sadaie R, et al. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine. 2007;25(21):4301-11. [
Link] [
DOI:10.1016/j.vaccine.2007.02.057] [
PMID]
34. Bastien P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg. 2002;96(Suppl 1):S205-15. [
Link] [
DOI:10.1016/S0035-9203(02)90078-7]
35. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47(4):554-66. [
Link] [
DOI:10.1086/590149] [
PMID]
36. Peyron F, Garweg JG, Wallon M, Descloux E, Rolland M, Barth J. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J. 2011;30(7):597-600. [
Link] [
DOI:10.1097/INF.0b013e31820bb5f3] [
PMID]
37. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis?. Mem Inst Oswaldo Cruz. 2009;104(2):320-44. [
Link] [
DOI:10.1590/S0074-02762009000200029]